Hot Features
プレミアム
Rigel Pharmaceuticals Inc (RIGL)
NASDAQ
登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。
| 日付 | 保有者名 | 取引株数 | 金額レンジ ($) | 取引種別 | 価格レンジ ($) | 届出終了時の株数 | % 変化 |
|---|---|---|---|---|---|---|---|
| 2026-06-22 | Ms. Kamil Ali JacksonIndependent Director | -2.50k | 87.50k | Automatic Disposition | 35.00 | 10.13k | -19.80% |
| 2026-06-01 | Mr. Dean L. SchornoExec. VP & CFO | -928.00 | 15.92k | Derivative Exercise and Sale | 12.70 - 29.86 | 38.19k | - |
| 2026-06-01 | Mr. Dean L. SchornoExec. VP & CFO | 2.45k | 38.35k | Derivative Exercise and Retained Stock | 12.70 - 18.70 | 38.19k | 6.86% |
| 2026-06-01 | Mr. David A. SantosExec. VP & Chief Commercial Officer | -874.00 | 26.10k | Sale to Issuer | 29.86 | 22.07k | -3.81% |
| 2026-06-01 | Mr. Raul R. RodriguezPresident, CEO & Director | -2.42k | 72.38k | Sale to Issuer | 29.86 | 181.14k | -1.32% |
| 2026-06-01 | Dr. Lisa Rojkjaerインサイダー | -850.00 | 25.38k | Sale to Issuer | 29.86 | 3.54k | -19.37% |
| 2026-06-01 | Mr. Raymond J. FureyExec. VP, CCO, General Counsel & Corporate Secretary | -877.00 | 26.19k | Sale to Issuer | 29.86 | 12.95k | -6.34% |
| 2026-05-26 | Ms. Kamil Ali JacksonIndependent Director | -2.50k | 72.93k | Automatic Disposition | 29.17 | 12.63k | -16.53% |
| 2026-02-20 | Dr. Walter H. MoosIndependent Director | -4.00k | 49.44k | Derivative Exercise and Sale | 24.00 - 36.36 | 10.22k | - |
| 2026-02-10 | Dr. Lisa Rojkjaerインサイダー | -3.76k | 130.10k | Sale to Issuer | 34.62 | 2.81k | -57.18% |
| 2026-02-10 | Mr. Raul R. RodriguezPresident, CEO & Director | -7.61k | 263.35k | Sale to Issuer | 34.62 | 179.07k | -4.07% |
| 2026-02-10 | Mr. David A. SantosExec. VP & Chief Commercial Officer | -3.55k | 122.76k | Sale to Issuer | 34.62 | 21.33k | -14.26% |
| 2026-02-10 | Mr. Dean L. SchornoExec. VP & CFO | -3.55k | 122.76k | Sale to Issuer | 34.62 | 34.02k | -9.44% |
| 2026-02-10 | Mr. Raymond J. FureyExec. VP, CCO, General Counsel & Corporate Secretary | -3.55k | 122.76k | Sale to Issuer | 34.62 | 12.21k | -22.51% |
| 2026-02-02 | Mr. David A. SantosExec. VP & Chief Commercial Officer | -5.72k | 205.91k | Sale to Issuer | 36.01 | 18.30k | -23.81% |
| 2026-01-26 | Mr. Raul R. RodriguezPresident, CEO & Director | 40.00k | 1.10M | Derivative Exercise and Retained Stock | 27.40 | 172.58k | 30.17% |
| 2026-01-26 | Mr. Raul R. RodriguezPresident, CEO & Director | -40.00k | 379.47k | Derivative Exercise and Sale | 27.40 - 37.00 | 172.58k | - |
| 2026-01-26 | Mr. Raul R. RodriguezPresident, CEO & Director | -44.75k | 1.65M | Sale to Issuer | 36.01 - 37.00 | 172.58k | -20.59% |
| 2026-02-02 | Mr. Raymond J. FureyExec. VP, CCO, General Counsel & Corporate Secretary | -3.97k | 142.89k | Sale to Issuer | 36.01 | 9.18k | -30.18% |
| 2026-02-02 | Mr. Dean L. SchornoExec. VP & CFO | -5.49k | 197.62k | Sale to Issuer | 36.01 | 30.99k | -15.05% |
| 2025-12-22 | Mr. Dean L. SchornoExec. VP & CFO | 6.50k | 139.79k | Derivative Exercise and Retained Stock | 18.70 - 24.20 | 26.19k | 33.02% |
ご覧いただいた銘柄が下記のボックス内に表示されますので、過去閲覧した銘柄情報に簡単にアクセスすることができます。
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約
メールアドレスで登録
すでにアカウントをお持ちですか？ サインイン
アカウントをお持ちでないですか？ 登録
登録することで、ADVFN の 利用規約 を読み、理解し、同意したこと、および私が個人投資家であることを確認します。
